A Phase 1/2 Study of BPI-361175 in Subjects With Advanced Solid Tumors
Clinical trial NCT05329298 · UNKNOWN
Trial details
- NCT number
- NCT05329298
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-21
- Primary completion
- 2023-06-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.